Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Gabriele Linden"'
Autor:
Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, Gabriele Linden, Peter Markus, Brigitte Schumacher, David Albers, Thomas Herold, Saskia Ting, Hartmut Schmidt, Sonja Radunz, Marcel Wiesweg, Jens Siveke, Martin Schuler, Stefan Kasper
Introduction: Gemcitabine and cisplatin is the standard first-line systemic treatment in patients with advanced cholangiocarcinoma (CCA). However, a substantial number of patients do not qualify for cisplatin due to comorbidities or poor performance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c7e430efae09aa408953217ba1ccc6
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85149815564
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85149815564
Autor:
Sandra Meyer-Moock, Daniel Szczotkowski, Leonie Schouten, Frank Petzke, Lena Milch, Beatrice Metz-Oster, Louise Zinndorf, Christian Geber, Greta Hoffmann, Anke Preißler, Ursula Marschall, Felix Rottke, Anja Waidner, André Möller, Thomas Isenberg, Gabriele Lindena, Anne Gärtner, Ulrike Kaiser, Thomas Kohlmann
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-19 (2024)
Abstract Background Up to 27% of the German population suffers from recurrent or persistent pain (lasting more than three months). Therefore, prevention of chronic pain is one major object of pain management interventions. The aim of this nationwide,
Externí odkaz:
https://doaj.org/article/84d44fb0f6904d51939d606d7d314f5c
Autor:
Isabel Virchow, Karl Worm, Tanja Trarbach, Winfried Berger, Saskia Ting, Brigitte Schumacher, Tilman Steinmetz, Thomas Höhler, Johannes Meiler, Martin Schuler, Peter Reimer, Gabriele Linden, Stefan Kasper, Thomas Herold, Marcel Wiesweg, Kurt Werner Schmid, Peter Markus, Heike Knipp, Alexander Dechêne, Karina Kostbade, Andreas Paul, Henning Reis
Background The multicenter, single-arm, phase II study CEBIFOX evaluated the efficacy of a biweekly cetuximab administration in combination with FOLFOX6 as first-line therapy in KRAS (exon 2) wild-type (wt) metastatic colorectal cancer (mCRC). Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5696b5ebc448e4c4fa8e944cdfb072ca
https://www.ncbi.nlm.nih.gov/pubmed/32737003
https://www.ncbi.nlm.nih.gov/pubmed/32737003
Publikováno v:
Molecular and Cellular Biochemistry. 183:105-112
We have characterized two abundant human cDNAs which, through Northern hybridization analysis, are selectively expressed in human sarcomeric muscle. DNA sequencing was performed and the two cDNAs were found to share sequence identity, with the except
Autor:
Jeremias Wohlschlaeger, Diana Cortes-Incio, Marcel Wiesweg, Silke Skottky, Peter Markus, Jens Köhler, Kurt Werner Schmid, Lutz Freitag, Mitra Tewes, Anja Welt, Cordula Derks, Andreas Paul, Stefan Kasper, Georgios Stamatis, Sebastian Bauer, Wilfried Eberhardt, Gabriele Linden, Alexander Dechêne, Martin Schuler, Frank Breitenbücher, Thomas Gauler, Peter Lütkes, Saskia Ting, Heike Richly, Karl Worm, Dirk Theegarten, Kaid Darwiche, Johannes Meiler, Jörg Hense, Henning Reis
Publikováno v:
European journal of cancer (Oxford, England : 1990). 49(15)
Purpose Multiple investigational drugs are currently explored in cancer patient populations defined by specific biomarkers. This demands a new process of patient selection for clinical trials. Patients and methods Starting January 1, 2012, preemptive
Autor:
Tanja Trarbach, Thomas Herold, Gabriele Linden, Saskia Ting, Karl Worm, Karina Kostbade, Peter Markus, Johannes Meiler, Brigitte Schumacher, Heike Knipp, Stefan Kasper, H.T. Steinmetz, Peter Reimer, Martin Schuler, T. Höhler, Kurt Werner Schmid, Winfried Berger, Andreas Paul, Alexander Dechêne
Publikováno v:
Annals of Oncology. 27:vi167
Autor:
Karina Kosbade, Kurt Werner Schmid, Tilman Steinmetz, Peter Reimer, Thomas Herold, Johannes Meiler, Martin Schuler, Tanja Trarbach, Saskia Ting, Andreas Paul, Winfried Berger, Brigitte Schumacher, Gabriele Linden, Alexander Dechêne, Karl Worm, Stefan Kasper, Heike Knipp, Thomas Hoehler, Peter Markus
Publikováno v:
Journal of Clinical Oncology. 33:3568-3568
3568 Background: The multicenter, single-arm, phase II CEBIFOX trial (Simon`s two stage minimax design) evaluated the efficacy of mFOLFOX6 + biweekly cetuximab (500 mg/m2) as 1st line therapy in KR...
Autor:
Saskia Ting, Stefan Kasper, Martin Schuler, Thomas Hoehler, Peter Markus, Andreas Paul, Heike Knipp, Tanja Trarbach, Tilman Steinmetz, Peter Reimer, Winfried Berger, Johannes Meiler, Gabriele Linden
Publikováno v:
Journal of Clinical Oncology. 31:e14502-e14502
e14502 Background: Combination of mFOLFOX6 with weekly cetuximab is a standard first line regimen in pts with KRAS wt mCRC. Weekly application of cetuximab increases the in-hospital time of pts with negative impact on quality of life. This multicentr
Autor:
Birgit Basedow-Rajwich, Thomas Montag, Andreas Duckert, Christian Schulz, Gennadij Rajwich, Ingo Kleiter, Jürgen Koehler, Gabriele Lindena
Publikováno v:
Palliative Care, Vol 11 (2018)
Context: During the last decade, numerous in-patient Palliative Care Consultation Service (PCCS) units were established throughout Germany. Objective: To provide an epidemiological overview on a whole year cohort of palliative patients in terms of de
Externí odkaz:
https://doaj.org/article/96d4e63a9a914460bc107c9936ab9610
Autor:
Sonja Hofmann, Stephanie Hess, Carsten Klein, Gabriele Lindena, Lukas Radbruch, Christoph Ostgathe
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0179415 (2017)
Anxiety is one of the most common psychological symptoms in patients in a palliative care situation. This study aims to develop a predictive model for anxiety using data from the standard documentation routine.Data sets of palliative care patients co
Externí odkaz:
https://doaj.org/article/a3246717e2644e94aa71e25dd5d3a72f